欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1723/001
药品名称
Amlodipin/Valsartan/Hydroklortiazid Teva
活性成分
amlodipine 5.0 mg
hydrochlorothiazide 12.5 mg
valsartan 160.0 mg
剂型
Film-coated tablet
上市许可持有人
Teva Sweden AB, Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Netherlands (NL)
Amlodipine/Valsartan/Hydrochloorthiazide Teva 5/160/12,5 mg, filmomhulde tabletten
Austria (AT)
Amlodipin/Valsartan/Hydrochlorothiazid ratiopharm 5 mg/160 mg/12,5 mg Filmtabletten
Spain (ES)
Latvia (LV)
Amlodipine/Valsartan/Hydrochlorothiazide Teva 5 mg/160 mg/12,5 mg apvalkotās tabletes
Lithuania (LT)
Amlodipine/Valsartan/ Hydrochlorothiazide Teva 5 mg/ 160 mg/ 12,5 mg plėvele dengtos tabletės
许可日期
2020/06/29
最近更新日期
2024/04/24
药物ATC编码
C09DX01 valsartan, amlodipine and hydrochlorothiazide
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PAR Summary
|
SE/H/1723/001_PAR Summary
Date of last change:2020/09/11
PAR
|
SE/H/1723/001_PAR
Date of last change:2020/09/11
Final PL
|
SE/H/1723/001_Final PL
Date of last change:2020/09/03
Final SPC
|
SE/H/1723/001_Final SPC
Date of last change:2020/09/03
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase